Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 42Lymphoma, Large B-Cell, Diffuse 34Burkitt Lymphoma 32Lymphoma 25Lymphoma, Follicular 17Rhabdomyosarcoma 13Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 13Lymphoma, B-Cell 11Neuroblastoma 10Lymphoma, Non-Hodgkin 10Leukemia 10Sarcoma, Ewing 9Medulloblastoma 9Leukemia, Biphenotypic, Acute 9Recurrence 8Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 8Neoplasms 8Lymphoma, T-Cell, Peripheral 8Lymphoma, Mantle-Cell 7Lymphoma, B-Cell, Marginal Zone 7Hodgkin Disease 7Wilms Tumor 5Sarcoma 5Retinoblastoma 5Osteosarcoma 4Lymphoproliferative Disorders 4Lymphoma, T-Cell 4Leukemia, Lymphocytic, Chronic, B-Cell 4Ganglioneuroblastoma 4Down Syndrome 4

Interventions

Vincristine 1Valganciclovir 1Therapeutics 1Rituximab 1Prednisone 1Positron-Emission Tomography 1Polymerase Chain Reaction 1Phacoemulsification 1Lenalidomide 1Ganciclovir 1Foscarnet 1Flow Cytometry 1Etoposide 1Doxorubicin 1Cyclophosphamide 1Antiviral Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Intraocular Lymphoma × Vincristine × 1 year × Clear all
NCT02213913 2026-03-11

Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas

University of Chicago

Phase 1/2 Completed
55 enrolled 17 charts
LymphoidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡